These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27472963)

  • 1. Oxidized LDL at the crossroads of immunity in non-alcoholic steatohepatitis.
    Houben T; Brandsma E; Walenbergh SMA; Hofker MH; Shiri-Sverdlov R
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Apr; 1862(4):416-429. PubMed ID: 27472963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MSP is a negative regulator of inflammation and lipogenesis in ex vivo models of non-alcoholic steatohepatitis.
    Chanda D; Li J; Oligschlaeger Y; Jeurissen ML; Houben T; Walenbergh SM; Shiri-Sverdlov R; Neumann D
    Exp Mol Med; 2016 Sep; 48(9):e258. PubMed ID: 27609031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic steatohepatitis: the role of oxidized low-density lipoproteins.
    Walenbergh SM; Koek GH; Bieghs V; Shiri-Sverdlov R
    J Hepatol; 2013 Apr; 58(4):801-10. PubMed ID: 23183522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-derived macrophages prone to accumulate lysosomal lipids trigger oxLDL-dependent murine hepatic inflammation.
    Houben T; Oligschlaeger Y; Bitorina AV; Hendrikx T; Walenbergh SMA; Lenders MH; Gijbels MJJ; Verheyen F; Lütjohann D; Hofker MH; Binder CJ; Shiri-Sverdlov R
    Sci Rep; 2017 Oct; 7(1):12550. PubMed ID: 28970532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.
    Zhao L; Zhang C; Luo X; Wang P; Zhou W; Zhong S; Xie Y; Jiang Y; Yang P; Tang R; Pan Q; Hall AR; Luong TV; Fan J; Varghese Z; Moorhead JF; Pinzani M; Chen Y; Ruan XZ
    J Hepatol; 2018 Sep; 69(3):705-717. PubMed ID: 29705240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of liver disease with postprandial large intestinal triglyceride-rich lipoprotein accumulation and pro/antioxidant imbalance in normolipidemic non-alcoholic steatohepatitis.
    Musso G; Gambino R; De Michieli F; Biroli G; Fagà E; Pagano G; Cassader M
    Ann Med; 2008; 40(5):383-94. PubMed ID: 18484349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immune regulatory networks in hepatic lipid metabolism.
    Bai L; Li H
    J Mol Med (Berl); 2019 May; 97(5):593-604. PubMed ID: 30891617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH).
    Nati M; Haddad D; Birkenfeld AL; Koch CA; Chavakis T; Chatzigeorgiou A
    Rev Endocr Metab Disord; 2016 Mar; 17(1):29-39. PubMed ID: 26847547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized Low-Density Lipoproteins Trigger Hepatocellular Oxidative Stress with the Formation of Cholesteryl Ester Hydroperoxide-Enriched Lipid Droplets.
    Sazaki I; Sakurai T; Yamahata A; Mogi S; Inoue N; Ishida K; Kikkai A; Takeshita H; Sakurai A; Takahashi Y; Chiba H; Hui SP
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronegative LDL is linked to high-fat, high-cholesterol diet-induced nonalcoholic steatohepatitis in hamsters.
    Lai YS; Yang TC; Chang PY; Chang SF; Ho SL; Chen HL; Lu SC
    J Nutr Biochem; 2016 Apr; 30():44-52. PubMed ID: 27012620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study.
    Imajo K; Hyogo H; Yoneda M; Honda Y; Kessoku T; Tomeno W; Ogawa Y; Taguri M; Mawatari H; Nozaki Y; Fujita K; Kirikoshi H; Saito S; Sumida Y; Ono M; Wada K; Nakajima A; Eguchi Y
    PLoS One; 2014; 9(12):e115403. PubMed ID: 25541989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
    Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP
    Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized Low-Density Lipoprotein Drives Dysfunction of the Liver Lymphatic System.
    Burchill MA; Finlon JM; Goldberg AR; Gillen AE; Dahms PA; McMahan RH; Tye A; Winter AB; Reisz JA; Bohrnsen E; Schafer JB; D'Alessandro A; Orlicky DJ; Kriss MS; Rosen HR; McCullough RL; Jirón Tamburini BA
    Cell Mol Gastroenterol Hepatol; 2021; 11(2):573-595. PubMed ID: 32961356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiological mechanisms and therapeutic potentials of macrophages in non-alcoholic steatohepatitis.
    Wu R; Nakatsu G; Zhang X; Yu J
    Expert Opin Ther Targets; 2016; 20(5):615-26. PubMed ID: 26609894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies.
    Musso G; Cassader M; Gambino R
    Nat Rev Drug Discov; 2016 Apr; 15(4):249-74. PubMed ID: 26794269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression.
    Loyer X; Paradis V; Hénique C; Vion AC; Colnot N; Guerin CL; Devue C; On S; Scetbun J; Romain M; Paul JL; Rothenberg ME; Marcellin P; Durand F; Bedossa P; Prip-Buus C; Baugé E; Staels B; Boulanger CM; Tedgui A; Rautou PE
    Gut; 2016 Nov; 65(11):1882-1894. PubMed ID: 26338827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will Studies in Nonalcoholic Steatohepatitis Help Manage Alcoholic Steatohepatitis?
    Sundaram V; Morgan TR
    Clin Liver Dis; 2019 Feb; 23(1):157-165. PubMed ID: 30454829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific immunization strategies against oxidized low-density lipoprotein: a novel way to reduce nonalcoholic steatohepatitis in mice.
    Bieghs V; van Gorp PJ; Walenbergh SM; Gijbels MJ; Verheyen F; Buurman WA; Briles DE; Hofker MH; Binder CJ; Shiri-Sverdlov R
    Hepatology; 2012 Sep; 56(3):894-903. PubMed ID: 22334337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic Steatohepatitis.
    Suzuki A; Diehl AM
    Annu Rev Med; 2017 Jan; 68():85-98. PubMed ID: 27732787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.